Maija Konstenius

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study
    Maija Konstenius
    Division of Psychiatry, Department of Clinical Neuroscience, Karolinska Institutet, 17176 Stockholm, Sweden
    Drug Alcohol Depend 108:130-3. 2010
  2. ncbi Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence
    Nitya Jayaram-Lindström
    Department of Clinical Neuroscience, Section for Alcohol and Drug Dependence Research, Karolinska Institutet, Stockholm, Sweden
    Neuropsychopharmacology 33:1856-63. 2008

Detail Information

Publications2

  1. ncbi Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study
    Maija Konstenius
    Division of Psychiatry, Department of Clinical Neuroscience, Karolinska Institutet, 17176 Stockholm, Sweden
    Drug Alcohol Depend 108:130-3. 2010
    ..No difference was found between the two groups with regards to craving for amphetamine or in retention in treatment. Larger studies with higher doses combined with individual dosage and longer follow-up periods are warranted...
  2. ncbi Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence
    Nitya Jayaram-Lindström
    Department of Clinical Neuroscience, Section for Alcohol and Drug Dependence Research, Karolinska Institutet, Stockholm, Sweden
    Neuropsychopharmacology 33:1856-63. 2008
    ..The results suggest that the subjective effects of amphetamine could be modulated via the endogenous opioid system. The potential of naltrexone as an adjunct pharmaceutical for amphetamine dependence is promising...